Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

90
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
90
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

128
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
128
Modeling in Therapy01:26

Modeling in Therapy

72
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
72
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

253
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
253
Drug Therapy01:28

Drug Therapy

43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
43
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

67
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood cognitive control as a predictor of long-term clinical and functional outcomes in Tourette syndrome.

Journal of child psychology and psychiatry, and allied disciplines·2026
Same author

Post-COVID-19 increases in depression and other psychiatric disorders among Saudi children and adolescents.

Frontiers in psychiatry·2026
Same author

Characterizing the Relationship Between Intervention Delivery and Outcomes Within Part C Community Settings.

Behavioral sciences (Basel, Switzerland)·2025
Same author

The Frith Prescribing Guidelines for People With Intellectual Disability, 4th Edition.

The Journal of neuropsychiatry and clinical neurosciences·2025
Same author

Clinical Correlates of Insomnia Symptoms in Young Children with Autism Spectrum Disorder.

The Journal of pediatrics·2025
Same author

Evaluating Intervention Fidelity and Adaptation Within Context: A Mixed-Methods Study of Implementation Practice Within Public Early Intervention Systems.

Implementation research and practice·2025

Related Experiment Video

Updated: Jul 1, 2025

Strategies for Assessing Autistic-Like Behaviors in Mice
07:38

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

970

Psychopharmacology Management in Autism Spectrum Disorder.

Jay A Salpekar1, Lawrence Scahill2

  • 1Neuropsychiatry Center, Kennedy Krieger Institute, Johns Hopkins University School of Medicine, 1741 Ashland Avenue, Baltimore, MD 21205, USA.

Pediatric Clinics of North America
|February 29, 2024
PubMed
Summary

Autism spectrum disorder (ASD) can co-occur with other psychiatric conditions. Psychopharmacologic agents, particularly second-generation antipsychotics, show promise for managing symptoms like irritability and hyperactivity in individuals with ASD.

Keywords:
AntipsychoticAutismAutism spectrum disorderBehaviorClinical trialNeuropsychiatryPsychopharmacologyTreatment

More Related Videos

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

1.6K
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

8.2K

Related Experiment Videos

Last Updated: Jul 1, 2025

Strategies for Assessing Autistic-Like Behaviors in Mice
07:38

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

970
Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

1.6K
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

8.2K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Developmental Disorders

Background:

  • Individuals with autism spectrum disorder (ASD) frequently experience comorbid psychiatric conditions.
  • Differentiating ASD-related traits from co-occurring symptoms can be challenging.
  • Neuronal hyperexcitability and altered brain connectivity in ASD may inform treatment strategies.

Purpose of the Study:

  • To review the potential role of psychopharmacologic interventions for psychiatric comorbidities in ASD.
  • To identify specific symptoms in ASD that are amenable to pharmacological treatment.
  • To highlight the current evidence for different classes of psychotropic medications.

Main Methods:

  • Literature review of studies on psychopharmacological treatments for ASD comorbidities.
  • Analysis of the pathophysiological underpinnings that support medication use.
  • Examination of clinical trial data for efficacy and safety.

Main Results:

  • Hyperactivity, irritability, and tantrums are key targets for intervention.
  • Second-generation antipsychotics are the most studied drug class for irritability in ASD.
  • Nonpharmacological strategies should also be considered.

Conclusions:

  • Psychopharmacological agents can be effective for managing specific psychiatric symptoms in ASD.
  • Further research is needed to optimize treatment protocols and explore novel therapeutic targets.
  • A multimodal approach combining medication and behavioral interventions is often optimal.